| __timestamp | Dynavax Technologies Corporation | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 90480000 |
| Thursday, January 1, 2015 | 22180000 | 133384000 |
| Friday, January 1, 2016 | 37257000 | 179997000 |
| Sunday, January 1, 2017 | 27367000 | 220119000 |
| Monday, January 1, 2018 | 64770000 | 258528000 |
| Tuesday, January 1, 2019 | 74986000 | 198205000 |
| Wednesday, January 1, 2020 | 79256000 | 181022000 |
| Friday, January 1, 2021 | 100156000 | 198359000 |
| Saturday, January 1, 2022 | 131408000 | 208789000 |
| Sunday, January 1, 2023 | 152946000 | 211124000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding financial trends is crucial. Over the past decade, Dynavax Technologies Corporation and MiMedx Group, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Dynavax's SG&A expenses surged by over 760%, reflecting strategic investments in growth and innovation. In contrast, MiMedx's expenses increased by approximately 133%, indicating a more stable financial strategy.
These trends highlight differing corporate strategies, with Dynavax aggressively expanding its operational footprint, while MiMedx maintains a steady course. Investors and stakeholders should consider these patterns when evaluating potential growth and risk factors.
Comparing SG&A Expenses: Merck & Co., Inc. vs MiMedx Group, Inc. Trends and Insights
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and MiMedx Group, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for Blueprint Medicines Corporation and Dynavax Technologies Corporation
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and Dynavax Technologies Corporation
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs MiMedx Group, Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Dynavax Technologies Corporation Trends and Insights
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Dynavax Technologies Corporation